57
Pediatric Oncology Pediatric Oncology

Pediatric Oncology

Embed Size (px)

DESCRIPTION

This powerpoint presentation is about children's oncology.

Citation preview

Page 1: Pediatric Oncology

Pediatric OncologyPediatric Oncology

Page 2: Pediatric Oncology

Why are we discussing Why are we discussing pediatric oncology?pediatric oncology?

• Childhood cancer accounts for only 2% of all cancer cases

• Childhood cancer has an overall survival rate of 80%– Acute Lymphocytic Leukemia (ALL)

is over 90%

Page 3: Pediatric Oncology

HOWEVER:HOWEVER:• Cancer is still the leading cause

of death in children from disease– Second to accidents

• Diagnosis is a life-changing one for the patient and all members of the family– Fear of the unknown difficult to

overcome and always in the background

Page 4: Pediatric Oncology

CausesCauses• Cancer by itself needs to be viewed as an assortment

of “genetic” diseases– Not to be confused with hereditary

• Cause is usually not determined• Most view cancer etiology as multifactorial• Types of cell damage

– Conversion of proto-oncogenes (regulate cell growth) into oncogenes (abnormal growth)

– Inactivation of tumor suppressor genes– Bypass of DNA repair gene that tells cell to die after

damaged– Two-hit model

Page 5: Pediatric Oncology

Acquired Capabilities of CancerAcquired Capabilities of Cancer

Essentials of Pediatric Oncology Nursing: A Core Curriculum, 2nd Ed. (2004) p. 16

Page 6: Pediatric Oncology

Characteristics of Childhood Ca Vs. Cancer in AdultsCharacteristics of Childhood Ca Vs. Cancer in Adults

Childhood• Rare 1-2% of all cases• Tissues CNS, muscle, bone,

reticuloendothelial system• Brief latency• Genetic alterations a major

role• Minimal opportunity for

prevention• Small opportunity for

screening

Adults• 98-99% of all cases• Organs-breast, lungs, colon,

prostate• Latency may be 20+ years• Environmental & lifestyle

factors more than genetics• 80% estimated to be

preventable• Many can be detected by

screening methods

Essentials of Pediatric Oncology Nursing: A Core Curriculum, 2nd Ed. (2004) p. 12

Page 7: Pediatric Oncology

Characteristics Characteristics (cont.)(cont.)

Childhood• Metastatic in 80% of cases• Pharmacokinetics

– Markedly different in children because of rapid developmental changes

– Many common tumor types responsive to chemo

– May tolerate higher doses & less difficulty with acute toxicity

– Vulnerable to long-term effects

• Genetic testing very rare• Treatment per research

protocols very common• Prognosis 70-90% cure

Adults• Local or regional disease• Pharmacokinetics

– Common tumor types less responsive to available chemo

– May have more difficulty with acute toxicity

– Less issues with long-term effects

• Genetic testing more common where available

• Treatment per research protocols less common

• Prognosis <60% cure Essentials of Pediatric Oncology Nursing: A Core Curriculum, 2nd Ed. (2004) p. 12

Page 8: Pediatric Oncology

7 Cardinal Signs of Ca in Children7 Cardinal Signs of Ca in Children• These signs can also occur in nonmalignant

conditions– Presence of a mass– Purpura– Pallor– Weight loss– Whitish reflex in the eye– Vomiting in the early AM– Recurrent or persistent fever

Page 9: Pediatric Oncology

5 More covert signs/symptoms5 More covert signs/symptoms• These also can easily occur in nonmalignant

conditions– Bone pain

• Increased concern if pain awakens child at night

– Headache• Especially in the morning upon awakening

– Persistent lymphadenopathy– Change in balance, gait, personality– Fatigue, malaise

Page 10: Pediatric Oncology

Diagnostic TestsDiagnostic Tests• CBC with diff• CMP• LDH• Alkaline Phosphate• Uric acid• Alpha fetoprotein• Cathecholamines (urine)• Cytogenetic studies• Chest x-ray

• Bone marrow– Aspirate and biopsy

• CT Scans• MRI• PET Scan• Bone Scan• Lumbar Puncture• Biopsies

These tests are disease/symptom specific

Page 11: Pediatric Oncology

Treatment for Childhood CancerTreatment for Childhood Cancer• Three major types of treatment

– Surgery• Can occur at different points of treatment plan• Biopsies• Staging• Debulking• Surgery due to complications of illness• Palliation• Placement of venous access devices

Page 12: Pediatric Oncology

Treatment of Childhood Ca Treatment of Childhood Ca (cont.)(cont.)

– Chemotherapy• Can occur by itself or with surgery and/or radiation• Goals

– Reduce tumor volume & prevent tumor cell division & spread– Designed to kill tumor cells during different phases of cell cycle– Given as combination agents to thus attack cells during different

stages at the same time– Goals can be

• Cure, control, and/or palliation

• Roles– Multimodal, Neoadjuvant, Adjuvant, Sanctuary, Palliative

• Modes of delivery– IV, PO, IM, IT

Page 13: Pediatric Oncology

Treatment of Childhood Ca Treatment of Childhood Ca (cont.)(cont.)

– Radiation Therapy (RT)• Goal is to target the tumor while sparing the surrounding

tissues• Causes single or double strand DNA breaks• Important to maintain Hgb >10

– Hypoxic cells are more resistant to RT

• Many different methods of delivery• Not used in all types of childhood ca

Page 14: Pediatric Oncology

LeukemiaLeukemia• Is a neoplastic disease that involves the blood-

forming tissues of the bone marrow, spleen, and lymph nodes

• During blood cell production the white blood cell precursors proliferate in an abnormal, uncontrolled, and destructive manner– These immature cells crowd into all available

spaces– Production of normal cells is limited due to lack of

space and nutrients

Page 15: Pediatric Oncology

Leukemia Leukemia (cont.)(cont.)

• The type of leukemia will depend on what cell line is affected and the level of cellular differentiation– ALL – Acute Lymphocytic leukemia

• 75-80%

– AML – Acute Myelogenous Leukemia• 2-25%

– CML – Chronic Myelocytic leukemia• Less than 5%

• Cytogenetic abnormalities are found in more than 90% of patients with ALL– Number of chromosomes and structure

Page 16: Pediatric Oncology

Presenting Signs/SymptomsPresenting Signs/Symptoms• Fever• Anemia

– Malaise, fatigue, pallor

• Thrombocytopenia– Bruises, petechiae, bleeding

• Hepatosplenomegaly• Bone pain (23% of cases)• Lymphadenopathy• CNS disease (less than 10% of cases at diagnosis)

– Headache, vomiting, visual disturbances

Page 17: Pediatric Oncology

TreatmentTreatment• Varies with diagnosis and risk group• AML receives induction chemotherapy to “clear”

marrow and put patient into remission (marrow clear of blasts cells)

• Frequently these patients will require an allogenic stem cell transplant if a matched related donor is available

• CNS prophylaxis is given to prevent CNS relapse– Treated even if CNS is “clean” at diagnosis

Page 18: Pediatric Oncology

Treatment for ALLTreatment for ALL• Divided into 3 phases• Induction (first month of therapy)

– Goal is to eliminate as many leukemia cells in marrow as possible

– During beginning of this period patients are at risk for tumor lysis syndrome

– Includes CNS treatment along with combination chemotherapy (IV, PO, IM)

• Consolidation (usually for around 1 year)– Includes CNS treatment along with chemotherapy– Requires more hospital admissions for chemo

Page 19: Pediatric Oncology

Treatment for ALL Treatment for ALL (cont.)(cont.)

• Maintenance (usually for 2-3 years)• Goals are:

– Maintain remission– Prevent drug resistance from developing– Minimize long-term side effects

• Includes CNS treatment along with combination chemotherapy (PO, IM, IV)

• Recurrent disease– Treatment will vary depending on when relapse

occurred

Page 20: Pediatric Oncology

Leukemia Case StudyLeukemia Case Study• 4 year old male with one week history of low

grade fevers and fatigue• Parents brought child to primary MD this

morning due to bruises they noticed• CBC done in the office lab showed peripheral

blasts• Child and parents sent to tertiary hospital for

admission and consult with oncology• Over the next 24-72 hrs diagnosis is made,

bone marrow & LP performed, central line is placed and treatment is begun

Page 21: Pediatric Oncology

Audience Participation TimeAudience Participation Time

• What types of issues would you the nurse have to address/deal with while caring for this patient/family?

• What important nursing routines need to occur?

Page 22: Pediatric Oncology

Nursing CareNursing Care• Emotional support• Strict I & O’s• Monitor labs• Blood products as

needed• Assist with procedures• Monitor for side effects

Pain relief

• Education– Illness– Treatment– Care at home– Effects on other family

members

• Administer chemo & other medications

• HANDWASHING!!REMEMBER- Care involves more than just the patient, includes parents, siblings, and possibly extended family members. Life-changing diagnosis with possible fatal outcome. Fear constantly in the background, lots of new information to absorb and grasp.

Page 23: Pediatric Oncology

OsteosarcomaOsteosarcoma• Malignant tumor of the

bone• Occurs earlier in

females– Due to growth spurt

• More common in males

• Usually affects long bones

• Predominately during 2nd decade of life

Males

Females

0

10

20

30

40

50

60

10 20 30 40

%

Page 24: Pediatric Oncology

Presenting Signs/SymptomsPresenting Signs/Symptoms• Pain

– Dull, aching, constant– Worse at night– Frequently attributed to trauma

• Swelling of soft tissue (possible)

• Altered gait (possible)

• 20% have visible metastatic disease (pulmonary) at initial diagnosis

Page 25: Pediatric Oncology

TreatmentTreatment• Combination chemotherapy• Surgery

– Limb salvage or amputation

• Continued chemotherapy• Usually at least one year for entire course• Patients need to be cautioned to be careful with

the affected limb prior to surgery– Pathologic fracture always a possibility

• If pulmonary mets present may need thoracotomy performed in the future

Page 26: Pediatric Oncology

Osteosarcoma Case StudyOsteosarcoma Case Study• 15 year old male has sports physical performed

and MD noted small amount of swelling on distal femur and pt c/o of increased pain while sleeping

• X-ray obtained and mass noted• Referred to orthopedic surgeon at tertiary

center– Biopsy performed and pt diagnosed with

osteosarcoma and referred to oncology– Diagnostic tests performed as an outpatient– Pt admitted 1 week later SDA s/p line placement

and will start chemotherapy this afternoon

Page 27: Pediatric Oncology

Audience Participation Time Again!Audience Participation Time Again!

• What differences do you see in this case study compared to leukemia case study?

• Anything different in terms of nursing care?

Page 28: Pediatric Oncology

Ewing’s SarcomaEwing’s Sarcoma

• Bone tumor– RADIOSENSITIVE

• May also develop in soft tissues

• Small, round, blue-cell tumor

• Translocation t (11;22)

• Caucasian (non-Hispanic) or Hispanic– Very rare in Asian or African descent

Page 29: Pediatric Oncology

Presenting Signs/SymptomsPresenting Signs/Symptoms• Pain

– Intermittent, present for 3-9 months

• Palpable mass

• Pathological fractures more common

• Fever may be present

Page 30: Pediatric Oncology

TreatmentTreatment

• Basically the same as osteosarcoma although the chemotherapy agents are different– Still chemo, surgery, more chemo

• Possible radiation therapy– Usually used if patient has reoccurrence

Page 31: Pediatric Oncology

Brain TumorsBrain Tumors• Most common solid tumor in childhood ca

– Astrocytomas (also called Gliomas)• 50% of all pediatric brain tumors• Malignant or benign depending on histology• Can occur in a variety of areas of the brain and/or spine

– Medulloblastoma• 25% of all pediatric brain tumors• Most common malignant CNS tumor• Usually in cerebellum or 4th ventricle

– Hydrocephalus often occurs

– Ependymoma (10% of all cases)

Page 32: Pediatric Oncology

Presenting Signs/SymptomsPresenting Signs/Symptoms• Symptoms vary depending on location of tumor• Sudden onset of symptoms more common in

aggressive tumors• Types of symptoms

– Headache (especially upon awakening in morning)– Vomiting– Ataxia– Nystagmus– Cranial nerve deficits– Visual changes– Seizures

Page 33: Pediatric Oncology

TreatmentTreatment• Surgery

– Goal is maximum resection of tumor• Frequently seen by neurosurgeon before oncologist

• Radiation therapy – Delayed in children <3yrs of age

• Chemotherapy– Used to delay radiation in younger children

• High dose chemotherapy followed by autologous stem cell transplant– Highly malignant tumors with minimal residual

disease

Page 34: Pediatric Oncology

NeuroblastomaNeuroblastoma• Most common extracranial solid tumor in

children (8-10%)

• Develops from neural crest cells– Anywhere along the sympathetic nervous system

• Chest, abdomen (may cross the midline), adrenal glands, head, pelvis

• Most common malignancy in infants– Diagnosis at < 1yr best prognosis– Phenomenon of spontaneous tumor regression &

maturation of the tumor can occur in this age group

Page 35: Pediatric Oncology

Neuroblastoma Neuroblastoma (cont.)(cont.)

• Usually diagnosed between age 2-5

• “silent tumor” – Widespread metastatic disease in 70% of pts at

diagnosis• Sites include

– Lymph nodes– Bone– Bone marrow– Liver – Subcutaneous tissue

• Hardened bluish nodules

• Rarely spreads to lung and brain

Page 36: Pediatric Oncology

Presenting Signs/SymptomsPresenting Signs/Symptoms• Pain

• Abdominal mass

• Malaise

• Cathecholamine secretion– HTN, flushing, excessive sweating, irritability

• Unique paraneoplastic syndrome (seen in 4% of pts)

– Opsomyoclonus• Myoclonic jerking and random eye movements

– Cerebellar ataxia

Page 37: Pediatric Oncology

TreatmentTreatment• Treatment & prognosis depend on staging and

age of child

• Includes:– Surgery– Chemo– Radiation– Stem cell transplant

Page 38: Pediatric Oncology

LymphomaLymphoma• Hodgkin’s & Non-Hodgkin’s Lymphoma (NHL)• NHL

– Malignant solid tumor of the immune system involving lymphoid cells

– Is a generalized disease at presentation– Disease spreads in a random, diffuse,

unpredictable, and aggressive manner• Quick diagnosis and rapid initiation of treatment is crucial

– Responds rapidly to chemo so need to be very watchful for tumor lysis syndrome

– Can involve T & B cell lines• Different subdivisions based on cell line involved

Page 39: Pediatric Oncology

Presenting Signs/SymptomsPresenting Signs/Symptoms• Vary with site of disease

– Abdomen• Pain, N/V, change in bowel habits, distension

– Mediastinum• Dysphagia, cough, wheeze, strider, superior vena cava

syndrome

– Head and Neck• Cervical lymphadenopathy, jaw swelling, unilateral

tonsillar enlargement

– Bone marrow• Pallor, anemia, thrombocytopenia

Page 40: Pediatric Oncology

Hodgkin’sHodgkin’s• A specific type of lymphoma that involves the

spleen and lymphatic system

• Characterized by binucleate or multinucleated giant cells

• 5% of all childhood cancers

• 3 distinct forms– Childhood (14 yr and younger)– Young adult (15-34)– Older adult (55-74)

Page 41: Pediatric Oncology

Presenting Signs/SymptomsPresenting Signs/Symptoms• Painless supraclavicular or cervical adenopathy

• 2/3 of pts have mediastinal involvement– Coughing, s/s of airway obstruction

• Fatigue

• Anorexia

• 3 constitutional “B” symptoms – (correlate with prognosis)– Unexplained fever above 38 C– Unexplained weight loss (10% within 6 months)– Drenching night sweats

Page 42: Pediatric Oncology

TreatmentTreatment

• Treatment – Either or both:

• Chemotherapy• Radiation therapy

• Children & adolescents in the favorable prognostic group have a 95% cure rate

Page 43: Pediatric Oncology

RetinoblastomaRetinoblastoma• Intraocular tumor

– 80% pts are under age 4 yrs– Familial form in 40% of cases

• Predisposed affected patient to secondary neoplasms

• Presentation– Leukocoria (cat’s eye reflex)

• Lack of normal red reflex of the eye

– Strabismus– Esotropia or exotropia– Decreased vision in one eye

Page 44: Pediatric Oncology

TreatmentTreatment

• Treatment (one or more of these therapies)– Enucleation– Radiation– Cryotherapy or thermotherapy– Chemotherapy– Laser photocoagulation

Page 45: Pediatric Oncology

Wilm’s TumorWilm’s Tumor• Tumor of the kidney

• 6% of all childhood cancers

• Familial cases 1-2%

• Presentation– Asymptomatic abdominal mass– (20-30% of pts)

• pain• Malaise• Hematuria• HTN

Page 46: Pediatric Oncology

TreatmentTreatment• Surgery

• Chemotherapy– Based on staging– Possibly prior to surgery

• Radiation therapy– Based on staging

• 80-more than 90% cure rate including stage IV disease

Page 47: Pediatric Oncology

RhabdomyosarcomaRhabdomyosarcoma• Tumors that arise from cells of skeletal muscle

lineage– Can occur in tissues in which striated muscle cells

are not normally found

• Presentation– Mass or disturbance of normal body function

• Head and neck including orbits (35%)• Genitourinary tract (22%)• Extremities (18%)• Other sites (25%)

– Trunk, pelvis, retroperitoneal, biliary tract, liver, brain, trachea, heart, breast, ovary

Page 48: Pediatric Oncology

General Nursing CareGeneral Nursing Care• Varies with what stage of illness is

occurring

• REMEMBER THIS IS A CHRONIC DISEASE WITH ACUTE PERIODS

• Teaching and reinforcement of teaching is common thread to all stages of illness

Page 49: Pediatric Oncology

Newly DiagnosedNewly Diagnosed• Many questions

• Need for emotional support

• Lots of important decisions to be made– In a fairly short period of time

• May want second opinion

• Lots of teaching

• Nursing needs– I & O -Surgical post-op

needs– Blood products -Reverse isolation

Page 50: Pediatric Oncology

TreatmentTreatment• Frequent admissions

– Weekly to q 3 weeks is norm

• I & O

• Large amount of hydration

• Chemo administration

• Monitor labs

• Supportive management– Nausea and vomiting

• Reinforce teaching

Page 51: Pediatric Oncology

Neutropenia Neutropenia other non-scheduled admitsother non-scheduled admits

• Neutropenia is the #1 dose-limiting symptom for chemotherapy

• Emergency admission– Can occur 7-10 days after chemo txment

• High risk for sepsis

• Close monitoring of v/s and labs

• Antibiotics -I & O

• -Supportive management– Pain, mucositis, fatigue

Page 52: Pediatric Oncology

End of TreatmentEnd of Treatment

• Happy to be over with treatments but fearful at same time to have them end– Support system from staff may be less– Fear of return of cancer– Change in routines

• Especially for younger patients

Page 53: Pediatric Oncology

ReoccurrenceReoccurrence

• No longer naïve-fully aware of what is involved

• Body tired from previous chemotherapy cycle– May develop side effects quicker and/or more

severely

• Reality that cure is less of a possibility

Page 54: Pediatric Oncology

End StageEnd Stage

• Acceptance of terminal stage may or may not have occurred

• Could be giving supportive care only

• May still be giving active treatment

Page 55: Pediatric Oncology

Survivorship IssuesSurvivorship Issues• Long term effects to major organ systems

– Renal, cardiac– Can occur many years after therapy completed

• Genetic issues

• Hearing impairments

• Hepatitis C

• Infertility and sexuality issues

• Insurance

Page 56: Pediatric Oncology

Survivorship Issues Survivorship Issues (cont.)(cont.)

• Learning disabilities

• Limb loss

• Secondary cancers

• Importance of yearly follow-ups with practitioners that are knowledgeable of survivorship issues!!

Page 57: Pediatric Oncology

• Life-changing diagnosis that affects the entire family

• Patient may be medical or surgical at different times in their treatment course

• Treatment courses can last for 1-3 years of more if relapses occur

• Fear in the background even if not obvious

• Try to encourage families to maintain normalcy as much as possible– Home, school, friends

• Balance your involvement!